In connection with the implementation of the project entitled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, within the framework of Contract No. 2022/ABM/06/00005-00 for funding of the Commercial Project under the Competition for the development of targeted or personalized medicine based on therapeutic products based on nucleic acids and small-molecule compounds, the Ordering Party is making a market discernment concerning The cost of purchasing a kit consisting of siRNA targeting MDMX mRNA (MDM4), Locus ID 4194, 3 unique siRNA duplexes (27-mer- 2 nmol each) (Locus ID 4194),control siRNA (27-mer, Negative control – 2 nmol) siRNA dissolution buffer, RNAase free – 2 mL
In order to submit an offer, please read the detailed content of the announcement included in the market research 138/2024 of the service and send the completed offer form.